Skip to content

Supplier News

Merck chairman Clark to retire

Richard Clark, chairman and former chief executive officer of Merck, plans to retire from the company and its board later this year. The pharmaceutical giant said Thursday that Clark, who has been with Merck nearly four decades, is slated to retire effective Dec. 1.

Teva offers assistance with inhaler phase-out

Teva Respiratory is providing resources for patients that will be affected by the phase-out of the over-the-counter asthma inhaler Primatene Mist. The Food and Drug Administration has mandated that inhalers containing chlorofluorocarbons (CFCs) be taken off the market after Dec.

Stopain to hit store shelves in Canada

Topical pain reliever Stopain is slated to become available to Canadian customers for the first time. Troy Healthcare, the maker of Stopain, said Monday that the topical analgesic will be rolled out to retailers across Canada this month through a partnership with ANB Canada.

Hyland’s names VP of sales

Les Hamilton has joined homeopathic medicine manufacturer Hyland’s Inc. as vice president of sales. Hyland’s said Monday that Hamilton comes to the company from The Emerson Group, where he served as field sales manager for seven years.

Carmex adds pump to skin care line

Carma Laboratories Inc. has expanded its skin care line with Carmex Healing Lotion in a new 13-ounce pump. Carmex Healing Lotion features aloe and vitamin E to moisturize, heal and protect skin from dryness, and it has a light, fresh scent and is formulated for daily use, Carma said.

Lannett to ship Loxitane generic

Lannett Co. has received approval from the Food and Drug Administration for loxapine capsules, an anti-psychotic medication. The generic pharmaceutical company said Tuesday that the loxapine capsules will be available in strengths of 5 mg, 10 mg, 25 mg and 50 mg.